重视脑梗死的出血性转化

[1] Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Practice: The Japan post-Marketing Alteplase Registration Study (J-MARS)[J] . Jyoji Nakagawara,Kazuo Minematsu,Yasushi Okada,Norio Tanahashi,Shinji Nagahiro,Etsuro Mori,Yukito Shinohara,Takenori Yamaguchi.Stroke . 2010 (9)

[2] Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTR[J] . Niaz Ahmed,Nils Wahlgren,Martin Grond,Michael Hennerici,Kennedy R Lees,Robert Mikulik,Mark Parsons,Risto O Roine,Danilo Toni,Peter Ringleb.Lancet Neurology . 2010 (9)

[3] Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials[J] . Kennedy R Lees,Erich Bluhmki,Rüdiger von Kummer,Thomas G Brott,Danilo Toni,James C Grotta,Gregory W Albers,Markku Kaste,John R Marler,Scott A Hamilton,Barbara C Tilley,Stephen M Davis,Geoffrey A Donnan,Werner Hacke.The Lancet . 2010 (9727)

[4] Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke: A Critical Review[J] . Martin J. O’Donnell,Graeme J. Hankey,John W. Eikelboom.Stroke . 2008 (5)

[5] Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction[J] . Richard I. Lindley,Joanna M. Wardlaw,Peter A.G. Sandercock,Prapan Rimdusid,Stephanie C. Lewis,David F. Signorini,Stefano Ricci.Journal of Stroke and Cerebrovascular Diseases . 2004 (6)

[6] Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages [J]. NEUROLOGY, 2003, 60 (03) : 511 - 513

[7] Cerebral Hemorrhagic Infarction at Autopsy: Cardiac Embolic Cause and the Relationship to the Cause of Death[J] . J. LODDER,B. KRUNE-KUBAT,J. BROEKMAN.Stroke . 1986 (4)

[8] High-dose atorvastatin after stroke or transient ischemic attack .2 The Stroke Prevention by Aggressive Reduction in Cholesterol Levels(SPARCL)Investigators. N Engl J Med . 2006

[1] Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Practice: The Japan post-Marketing Alteplase Registration Study (J-MARS)[J] . Jyoji Nakagawara,Kazuo Minematsu,Yasushi Okada,Norio Tanahashi,Shinji Nagahiro,Etsuro Mori,Yukito Shinohara,Takenori Yamaguchi.Stroke . 2010 (9)

[2] Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTR[J] . Niaz Ahmed,Nils Wahlgren,Martin Grond,Michael Hennerici,Kennedy R Lees,Robert Mikulik,Mark Parsons,Risto O Roine,Danilo Toni,Peter Ringleb.Lancet Neurology . 2010 (9)

[3] Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials[J] . Kennedy R Lees,Erich Bluhmki,Rüdiger von Kummer,Thomas G Brott,Danilo Toni,James C Grotta,Gregory W Albers,Markku Kaste,John R Marler,Scott A Hamilton,Barbara C Tilley,Stephen M Davis,Geoffrey A Donnan,Werner Hacke.The Lancet . 2010 (9727)

[4] Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke: A Critical Review[J] . Martin J. O’Donnell,Graeme J. Hankey,John W. Eikelboom.Stroke . 2008 (5)

[5] Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction[J] . Richard I. Lindley,Joanna M. Wardlaw,Peter A.G. Sandercock,Prapan Rimdusid,Stephanie C. Lewis,David F. Signorini,Stefano Ricci.Journal of Stroke and Cerebrovascular Diseases . 2004 (6)

[6] Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages [J]. NEUROLOGY, 2003, 60 (03) : 511 - 513

[7] Cerebral Hemorrhagic Infarction at Autopsy: Cardiac Embolic Cause and the Relationship to the Cause of Death[J] . J. LODDER,B. KRUNE-KUBAT,J. BROEKMAN.Stroke . 1986 (4)

[8] High-dose atorvastatin after stroke or transient ischemic attack .2 The Stroke Prevention by Aggressive Reduction in Cholesterol Levels(SPARCL)Investigators. N Engl J Med . 2006